- About Us
- Clinical Trials
Available Clinical Trials
- Resources
- Contact Us
STAMP: Surgically Treated Adjuvant Merkel cell carcinoma with Pembrolizumab, a Phase III Trial
Eligible for screening study DCP 001
EA6174 is closed to accrual, effective July 1, 2024.